Published in Neurology on April 01, 1987
Recommendations for the pharmacological management of neuropathic pain: an overview and literature update. Mayo Clin Proc (2010) 3.92
Diabetic neuropathy: mechanisms to management. Pharmacol Ther (2008) 2.57
Distal Symmetric Polyneuropathy: A Review. JAMA (2015) 2.10
Diabetic neuropathy: clinical manifestations and current treatments. Lancet Neurol (2012) 1.99
Clinical practice guidelines for treatment of diabetes mellitus. Expert Committee of the Canadian Diabetes Advisory Board. CMAJ (1992) 1.90
Leg symptoms in outpatient veterans. West J Med (1991) 1.69
Brain indoleamine 2,3-dioxygenase contributes to the comorbidity of pain and depression. J Clin Invest (2012) 1.51
Antidepressants as analgesics: a review of randomized controlled trials. J Psychiatry Neurosci (2001) 1.40
Antidepressant Use in Chronic Pain Management: Is There Evidence of a Role for Duloxetine? Prim Care Companion J Clin Psychiatry (2003) 1.12
Animal models of peripheral neuropathies. Neurotherapeutics (2012) 1.09
Meta-analysis of duloxetine vs. pregabalin and gabapentin in the treatment of diabetic peripheral neuropathic pain. BMC Neurol (2009) 1.03
Nociceptive and neuropathic pain in patients with lung cancer: a comparison of pain quality descriptors. J Pain Symptom Manage (2001) 1.03
Topical application of doxepin hydrochloride, capsaicin and a combination of both produces analgesia in chronic human neuropathic pain: a randomized, double-blind, placebo-controlled study. Br J Clin Pharmacol (2000) 1.03
Exacerbated mechanical allodynia in rats with depression-like behavior. Brain Res (2008) 0.98
National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: V. The 2014 Ancillary Therapy and Supportive Care Working Group Report. Biol Blood Marrow Transplant (2015) 0.98
Sleep and duodenal motor activity in patients with severe non-ulcer dyspepsia. Gut (1994) 0.98
Sensory neuropathies including painful and toxic neuropathies. J Neurol (1997) 0.96
Translational investigation and treatment of neuropathic pain. Mol Pain (2012) 0.95
Antidepressants inhibit P2X4 receptor function: a possible involvement in neuropathic pain relief. Mol Pain (2009) 0.95
Polyneuropathy with Impaired Glucose Tolerance: Implications for Diagnosis and Therapy. Curr Treat Options Neurol (2005) 0.93
Anti-nociception is selectively enhanced by parallel inhibition of multiple subtypes of monoamine transporters in rat models of persistent and neuropathic pain. Psychopharmacology (Berl) (2005) 0.91
Clomipramine vs desipramine vs placebo in the treatment of diabetic neuropathy symptoms. A double-blind cross-over study. Br J Clin Pharmacol (1990) 0.90
Diabetic neuropathy and oxidative stress: therapeutic perspectives. Oxid Med Cell Longev (2013) 0.90
Chronic curcumin treatment normalizes depression-like behaviors in mice with mononeuropathy: involvement of supraspinal serotonergic system and GABAA receptor. Psychopharmacology (Berl) (2013) 0.89
Depression-like behavior and mechanical allodynia are reduced by bis selenide treatment in mice with chronic constriction injury: a comparison with fluoxetine, amitriptyline, and bupropion. Psychopharmacology (Berl) (2010) 0.89
Targeting voltage-gated calcium channels: developments in peptide and small-molecule inhibitors for the treatment of neuropathic pain. Br J Pharmacol (2012) 0.89
Influence of the CYP2D6*4 polymorphism on dose, switching and discontinuation of antidepressants. Br J Clin Pharmacol (2007) 0.88
Treatment of diabetic sensory polyneuropathy. Curr Treat Options Neurol (2011) 0.86
A combined effect of dextromethorphan and melatonin on neuropathic pain behavior in rats. Brain Res (2009) 0.85
Gabapentin versus tricyclic antidepressants for diabetic neuropathy and post-herpetic neuralgia: discrepancies between direct and indirect meta-analyses of randomized controlled trials. J Gen Intern Med (2008) 0.85
Sitagliptin, sitagliptin and metformin, or sitagliptin and amitriptyline attenuate streptozotocin-nicotinamide induced diabetic neuropathy in rats. J Biomed Res (2012) 0.84
Research designs for proof-of-concept chronic pain clinical trials: IMMPACT recommendations. Pain (2014) 0.84
Painful diabetic neuropathy: an update. Ann Neurosci (2011) 0.83
Fibromyalgia and depression. Pain Res Treat (2011) 0.83
A greater role for the norepinephrine transporter than the serotonin transporter in murine nociception. Neuroscience (2010) 0.83
Neurologic Complications of Cancer Therapy. Curr Treat Options Neurol (1999) 0.82
Duloxetine in the long-term management of diabetic peripheral neuropathic pain: An open-label, 52-week extension of a randomized controlled clinical trial. Curr Ther Res Clin Exp (2006) 0.81
Pain management part II: pharmacologic management of chronic orofacial pain. Anesth Prog (2010) 0.80
Impairment, disability, or handicap in peripheral neuropathy: analysis of the use of outcome measures in clinical trials in patients with peripheral neuropathies. J Neurol Neurosurg Psychiatry (1995) 0.79
The management of diabetic neuropathy in CKD. Am J Kidney Dis (2009) 0.79
Paroxetine for somatic pain associated with physical illness: a review. Prim Care Companion J Clin Psychiatry (2006) 0.78
Pain and psychiatry: a critical analysis and pharmacological review. Clin Pract Epidemiol Ment Health (2006) 0.78
An integrated perspective on diabetic, alcoholic, and drug-induced neuropathy, etiology, and treatment in the US. J Pain Res (2017) 0.78
Investigational pharmacology for low back pain. J Pain Res (2010) 0.77
Endogenous monoamine analgesic systems: amitriptyline in painful diabetic neuropathy. Anesth Prog (1987) 0.77
Utilization and mechanism of action of tricyclic antidepressants in the treatment of chronic facial pain: a review of the literature. Anesth Prog (1991) 0.76
The effect of transdermal nitroglycerin on pain control in diabetic patients with peripheral neuropathy. J Diabetes Metab Disord (2015) 0.76
Pain associated with diabetic peripheral neuropathy: a review of available treatments. P T (2008) 0.76
Low-dose amitriptyline for treatment of persistent arm pain due to repetitive use. Pain (2010) 0.75
Brief reports from the pain management symposium. Nonopioid analgesics. Proc (Bayl Univ Med Cent) (2000) 0.75
Gabapentin induced cholestasis. BMJ (2002) 0.75
Linezolid is associated with serotonin syndrome in a patient receiving amitriptyline, and fentanyl: a case report and review of the literature. Case Rep Psychiatry (2013) 0.75
Common pain syndromes and their management. Can J Anaesth (1989) 0.75
A retrospective study of amitriptyline in youth with autism spectrum disorders. J Autism Dev Disord (2013) 0.75
A new and sensitive method for measuring thermal nociception in cutaneous hyperalgesia. Pain (1988) 18.17
A novel behavioral model of neuropathic pain disorders produced in rats by partial sciatic nerve injury. Pain (1990) 4.51
The cortical representation of pain. Pain (1999) 3.96
Pain measurement: an overview. Pain (1985) 3.54
Opioids versus antidepressants in postherpetic neuralgia: a randomized, placebo-controlled trial. Neurology (2002) 3.21
Effects of desipramine, amitriptyline, and fluoxetine on pain in diabetic neuropathy. N Engl J Med (1992) 2.96
Imipramine in patients with chest pain despite normal coronary angiograms. N Engl J Med (1994) 2.80
Evidence for two distinct perceptual alterations in irritable bowel syndrome. Gut (1997) 2.77
Towards a mechanism-based classification of pain? Pain (1998) 2.73
Peripheral suppression of first pain and central summation of second pain evoked by noxious heat pulses. Pain (1977) 2.60
A prospective randomized trial of regional versus systemic continuous 5-fluorodeoxyuridine chemotherapy in the treatment of colorectal liver metastases. Ann Surg (1987) 2.54
Ratio scales of sensory and affective verbal pain descriptors. Pain (1978) 2.39
Response properties and receptive fields of cells in an anatomically defined region of the superior temporal sulcus in the monkey. Brain Res (1971) 2.06
Influence of psychological factors on risk of temporomandibular disorders. J Dent Res (2007) 2.02
Mechanism-based pain diagnosis: issues for analgesic drug development. Anesthesiology (2001) 1.93
Pituitary metastasis: incidence in cancer patients and clinical differentiation from pituitary adenoma. Neurology (1981) 1.78
Capsaicin-evoked mechanical allodynia and hyperalgesia cross nerve territories. Evidence for a central mechanism. Anesthesiology (1996) 1.70
Tourniquet constriction exacerbates hyperalgesia-related pain induced by intradermal capsaicin injection. Anesthesiology (1999) 1.60
AMPA/kainate antagonist LY293558 reduces capsaicin-evoked hyperalgesia but not pain in normal skin in humans. Anesthesiology (1998) 1.57
Stimulation in the human somatosensory thalamus can reproduce both the affective and sensory dimensions of previously experienced pain. Nat Med (1995) 1.56
Physiology and morphology of substantia gelatinosa neurons intracellularly stained with horseradish peroxidase. J Comp Neurol (1980) 1.53
Congenital localized absence of the skin as a manifestation of epidermolysis bullosa. Arch Dermatol (1992) 1.51
Pain and hyperalgesia following tissue injury: new mechanisms and new treatments. Pain (1991) 1.50
Validity and sensitivity of ratio scales of sensory and affective verbal pain descriptors: manipulation of affect by diazepam. Pain (1978) 1.47
Clinicians' expectations influence placebo analgesia. Lancet (1985) 1.46
The pharmacokinetics of heroin in patients with chronic pain. N Engl J Med (1984) 1.46
Narcotic analgesia: fentanyl reduces the intensity but not the unpleasantness of painful tooth pulp sensations. Science (1979) 1.41
Safety of the maternal-infant zidovudine regimen utilized in the Pediatric AIDS Clinical Trial Group 076 Study. AIDS (1998) 1.40
Sentinel node biopsy for melanoma: what is the evidence? Arch Dermatol (2001) 1.40
Dried blood spots for the diagnosis and quantitation of HIV-1: stability studies and evaluation of sensitivity and specificity for the diagnosis of infant HIV-1 infection in Thailand. J Virol Methods (2008) 1.39
Unilateral decrease in thalamic activity observed with positron emission tomography in patients with chronic neuropathic pain. Pain (1995) 1.37
A multiple random staircase method of psychophysical pain assessment. Pain (1988) 1.36
Spinal and trigeminal mechanisms of nociception. Annu Rev Neurosci (1983) 1.36
A validation model for verbal description scaling of human clinical pain. Pain (1980) 1.34
Neural activation during acute capsaicin-evoked pain and allodynia assessed with PET. Brain (1998) 1.33
Conscious sedation with intravenous drugs: a study of amnesia. J Oral Surg (1978) 1.33
Response of unmyelinated (C) polymodal nociceptors to thermal stimuli applied to monkey's face. J Neurophysiol (1976) 1.29
Enhanced descending modulation of nociception in rats with persistent hindpaw inflammation. J Neurophysiol (1996) 1.26
Diabetes impairs the late inflammatory response to wound healing. J Surg Res (1991) 1.25
A randomized trial of amitriptyline and mexiletine for painful neuropathy in HIV infection. AIDS Clinical Trial Group 242 Protocol Team. Neurology (1998) 1.21
Changes in gene expression and neuronal phenotype in brain stem pain modulatory circuitry after inflammation. J Neurophysiol (2002) 1.20
Spatial and temporal transformations of input to spinothalamic tract neurons and their relation to somatic sensations. J Neurophysiol (1978) 1.20
Desipramine relieves postherpetic neuralgia. Clin Pharmacol Ther (1990) 1.20
Amitriptyline, but not lorazepam, relieves postherpetic neuralgia. Neurology (1988) 1.18
Association of galanin haplotypes with alcoholism and anxiety in two ethnically distinct populations. Mol Psychiatry (2006) 1.18
Placebo and naloxone can alter post-surgical pain by separate mechanisms. Nature (1984) 1.18
Thermal and pain sensations evoked by microstimulation in the area of human ventrocaudal nucleus. J Neurophysiol (1993) 1.17
Orofacial deep and cutaneous tissue inflammation and trigeminal neuronal activation. Implications for persistent temporomandibular pain. Cells Tissues Organs (2001) 1.16
Opioid analgesia at peripheral sites: a target for opioids released during stress and inflammation? Anesth Analg (1987) 1.16
High-dose oral dextromethorphan versus placebo in painful diabetic neuropathy and postherpetic neuralgia. Neurology (1997) 1.14
Central nervous system plasticity and persistent pain. J Orofac Pain (1999) 1.14
Trigeminothalamic neurons in nucleus caudalis responsive to tactile, thermal, and nociceptive stimulation of monkey's face. J Neurophysiol (1976) 1.14
A peripheral "cold" fiber population responsive to innocuous and noxious thermal stimuli applied to monkey's face. J Neurophysiol (1975) 1.11
Bradykinin is increased during acute and chronic inflammation: therapeutic implications. Clin Pharmacol Ther (1988) 1.10
Spinal opioid analgesic effects are enhanced in a model of unilateral inflammation/hyperalgesia: possible involvement of noradrenergic mechanisms. Eur J Pharmacol (1991) 1.09
A brainstem substrate for analgesia elicited by intraoral sucrose. Neuroscience (2005) 1.09
Activity of trigeminothalamic neurons in medullary dorsal horn of awake monkeys trained in a thermal discrimination task. J Neurophysiol (1984) 1.08
SI nociceptive neurons participate in the encoding process by which monkeys perceive the intensity of noxious thermal stimulation. Brain Res (1988) 1.08
Immunohistochemical staining for androgen receptors: a sensitive marker of sebaceous differentiation. Am J Dermatopathol (1999) 1.08
Cloning of a DNA binding protein that is a tyrosine kinase substrate and recognizes an upstream initiator-like sequence in the promoter of the preprodynorphin gene. Brain Res Mol Brain Res (1994) 1.07
Wide-dynamic-range dorsal horn neurons participate in the encoding process by which monkeys perceive the intensity of noxious heat stimuli. Brain Res (1986) 1.06
Support for the involvement of TPH2 gene in affective disorders. Mol Psychiatry (2004) 1.06
Abnormal cardiac sensitivity in patients with chest pain and normal coronary arteries. J Am Coll Cardiol (1990) 1.05
Persistent Fos protein expression after orofacial deep or cutaneous tissue inflammation in rats: implications for persistent orofacial pain. J Comp Neurol (1999) 1.05
The pilo-Ruffini complex: a non-sinus hair and associated slowly-adapting mechanoreceptor in primate facial skin. Brain Res (1978) 1.05
Mechanisms of first and second pain in the peripheral and central nervous systems. J Invest Dermatol (1977) 1.05
Opiates suppress carrageenan-induced edema and hyperthermia at doses that inhibit hyperalgesia. Pain (1990) 1.04
Evaluation of multi-dimensional pain scales. Pain (1992) 1.03
Efficacy of desipramine in painful diabetic neuropathy: a placebo-controlled trial. Pain (1991) 1.03